Excretion into breast milk is insignificant and no adverse effects reported in breasted infants. Es considerada medicación compatible con la lactancia por autores y sociedades científicas relevantes (Rowe 2013, Nahum 2006, Mahadevan 2006, Bar-Oz 2003, CDC 2001, Fulton 1992). Es una medicación de uso común en Pediatría y considerado medicamento esencial para uso pediátrico por la OMS (WHO 2013). The possible negativity of cultures in febrile infants whose mothers take antibiotics should be taken into account, as well as the possibility of gastroenteritis due to altered intestinal flora (Benyamini 2005, Ito 1993, Kafetzis 1981). American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).List of WHO essential medicines: compatible with breastfeeding (WHO / UNICEF 2002).